ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Respiratory Tract Diseases
Chronic Obstructive Pulmonary Disease
Conjunctivitis
Dust Mite Allergy

Asthma trials near New Haven, CT, USA:

REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study

study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...

Active, not recruiting
Asthma
Other: Spirometry
Drug: Mepolizumab

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

New Haven, Connecticut, United States and 64 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Hawthorne, New York, United States and 335 other locations

and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Atuliflapon

Phase 2

AstraZeneca
AstraZeneca

Valhalla, New York, United States and 233 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Enrolling
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Hawthorne, New York, United States and 74 other locations

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...

Enrolling
Asthma
Drug: dupilumab
Drug: Matching Placebo

Phase 4

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

New York, New York, United States and 83 other locations

administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...

Active, not recruiting
Asthma
Device: Inhaler
Drug: AZD8630

Phase 2

AstraZeneca
AstraZeneca

New Haven, Connecticut, United States and 195 other locations

inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs).Secondary Objectives:To evaluate the efficacy...

Enrolling
Asthma
Drug: Albuterol sulfate
Drug: TEV-56248

Phase 3

Teva Pharmaceuticals
Teva Pharmaceuticals

Hawthorne, New York, United States and 393 other locations

MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis...

Enrolling
Asthma
Combination Product: BDA MDI
Combination Product: AS MDI

Phase 3

AstraZeneca
AstraZeneca

Hawthorne, New York, United States and 125 other locations

The objectives of this clinical trial are to evaluate the safety and tolerability of topically applied ATR12-351, to understand what the body does to...

Enrolling
Netherton Syndrome
Drug: ATR12-351

Phase 1

Azitra

New Haven, Connecticut, United States and 1 other location

The innovative platform MILC is designed to provide an integrated and comprehensive professional and social support network with personalized breastf...

Not yet enrolling
Breastfeeding, Exclusive
Behavioral: Usual care
Behavioral: MILC application
Benten Technologies

Farmington, Connecticut, United States and 2 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems